Healthcare Triangle Pursues Up to $30 Million Roboticom Asset Deal
Sep 23, 2026
Acquisitions
Trinity Capital Invests $45 Million in Rapid Micro Biosystems
Sep 22, 2025
Trinity Capital has committed $45 million in growth capital to Rapid Micro Biosystems to support its automation solutions in healthcare manufacturing.
Trinity Capital Inc. has committed $45 million in growth capital to Rapid Micro Biosystems, announced in a press release. Rapid Micro Biosystems specializes in automating microbial quality control processes, which are crucial for the efficient manufacturing and safe release of healthcare products.
The investment will aid in scaling Rapid Micro's operations, including the global expansion of its Growth Direct platform. This platform automates microbial quality control testing, providing faster and more accurate results, thereby enhancing operational efficiency and data integrity. The funding will also support efforts to reduce product costs and improve manufacturing efficiencies.
Robert Spignesi, President and CEO of Rapid Micro Biosystems, expressed satisfaction with the partnership, highlighting the shared vision of automating manual testing methods in biopharma manufacturing. This financial boost is expected to strengthen Rapid Micro's market position and support its long-term growth objectives.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 KBRA Rated Anthropic BB+ Before $35 Billion Chip Financing Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 Intuit Agrees to Acquire AI Billing Startup Sequence for Reported $200 Million Oct 16 Matters Raises $5 Million to Build AI Consumer BankMore from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Rapta Raises $8 Million for Manufacturing Quality Assurance AI
Sep 17, 2026
Funding
D-Robotics Raises $400 Million for Robotics Chips and Software
Sep 17, 2026
Chips
ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
Sep 24, 2026
Biotech
RapidCanvas Raises $29 Million to Expand Enterprise AI Platform
Oct 16, 2026
Funding
Immunomatics Receives $100,000 Investment From GenDx Cofounder
Oct 07, 2026
Funding
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.